AEON Biopharma Posts Updated Investor Presentation Under Reg FD
at www.tipranks.com (Fri, 23-Oct 4:52 PM)
AEON climbs as FDA Type 2b feedback supports a potentially streamlined ABP-450 biosimilar path
Market Chameleon (Wed, 30-Sep 11:36 AM)
Market Chameleon (Tue, 25-Aug 10:31 AM)